Ligandal

About:

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

Website: http://www.ligandal.com

Twitter/X: Ligandal

Top Investors: Propel(X), Social Capital, Social Impact Capital, Esther Dyson, Bioverge

Description:

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.

Total Funding Amount:

$4.64M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2014-01-01

Contact Email:

press(AT)ligandal.com

Founders:

Andre Watson, Christian Foster

Number of Employees:

1-10

Last Funding Date:

2019-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai